Context
- Researchers from the Indian Institute of Science (IISc), Bengaluru, and TCG-CREST, Kolkata have identified a brain circuit involved in chemotherapy-induced cold allodynia.
- Published in Cell Reports, the study explains how abnormal cold pain is processed in the brain and may help in developing more targeted treatments in the future.
What Is Cold Allodynia?
- Cold allodynia is a form of neuropathic pain in which a normally harmless cold stimulus is felt as painful.
- Common symptoms include burning pain, tingling, pins-and-needles sensation and severe discomfort on exposure to mild cold.
- It can occur as part of chemotherapy-induced peripheral neuropathy (CIPN), which refers to nerve damage caused by certain anticancer drugs.
Why Can Chemotherapy Cause It?
- Oxaliplatin: Cold allodynia is commonly associated with oxaliplatin, a platinum-based chemotherapy drug used to treat several cancers.
- Oxaliplatin can disturb normal signalling in sensory nerves, causing harmless cold sensations to generate abnormal pain signals.
- These changes can persist within the nervous system, which may explain why pain sometimes continues even after peripheral nerves begin to recover.
What Did the New Study Find?
- Brain circuit: Researchers identified a pathway connecting the lateral parabrachial nucleus (LPBN) in the brainstem with the parafascicular region of the thalamus.
- Role of the circuit: It is involved in both the sensation of cold pain and the distress or avoidance behaviour associated with that pain.
- Experimental methods: Researchers used calcium imaging, electrophysiology, optogenetics and chemo genetics to study and manipulate the pathway in mice.
- Causal role: Altering the activity of this circuit changed cold-pain behaviour in mice, indicating that the pathway directly contributes to cold allodynia.
Other Causes
Cold allodynia may also develop when diseases or injuries disturb normal sensory nerve signaling.
- Diabetes: Diabetic neuropathy can damage peripheral nerves and alter pain perception.
- Viral infections: Conditions such as shingles may cause persistent neuropathic pain.
- Nerve injury: Trauma can disturb normal processing of temperature and pain signals.
- Vitamin B12 deficiency: Severe deficiency can damage nerves and contribute to neuropathy.
Why Is the Discovery Important?
- Understanding chronic pain: The study shows that chemotherapy-related pain involves changes in the brain as well as peripheral nerve damage.
- Targeted therapies: Identifying a specific neural pathway provides a possible biological target for future pain treatments.
- Cancer care: Better control of neuropathic pain could improve the quality of life of cancer patients undergoing chemotherapy.
- Pain neuroscience: The study improves understanding of how the brain links the physical sensation of pain with its emotional response.
Management
- Medicines: Drugs such as duloxetine, pregabalin or gabapentin may be used for neuropathic pain under medical supervision.
- Cold avoidance: Limiting exposure to very cold objects, drinks and environments can help reduce symptoms.
- Future treatment: The newly identified brain circuit is still a research target; brain-circuit-based treatment has not yet been established in humans.
Thus, cold allodynia is not simply increased sensitivity to cold; it is pain caused by a cold stimulus that would normally not be painful.
Cold Allodynia FAQs
Q1. Which chemotherapy drug is particularly associated with cold allodynia?
Oxaliplatin, a platinum-based anticancer drug, is strongly associated with chemotherapy-induced cold sensitivity.
Q2. Which brain regions were identified in the recent study?
The study identified a pathway connecting the lateral parabrachial nucleus with the parafascicular region of the thalamus.
Q3. Why was manipulation of the brain circuit important?
Changing its activity altered cold-pain behaviour in mice, showing that the circuit plays an active role in producing the pain response.
Q4. Is cold allodynia the same as hyperalgesia?
No. Allodynia causes pain from a normally harmless stimulus, while hyperalgesia increases pain from an already painful stimulus.
Q5. Has this discovery produced a treatment for patients?
Not yet. The identified circuit is a promising research target, but its therapeutic use in humans requires further study.
